关注
Pieter De Visschere
Pieter De Visschere
在 ugent.be 的电子邮件经过验证
标题
引用次数
引用次数
年份
Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature
JJ Fütterer, A Briganti, P De Visschere, M Emberton, G Giannarini, ...
European urology 68 (6), 1045-1053, 2015
9182015
EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU …
JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ...
European urology 77 (2), 223-250, 2020
1922020
A systematic review on the role of imaging in early recurrent prostate cancer
PJL De Visschere, C Standaert, JJ Fütterer, GM Villeirs, V Panebianco, ...
European urology oncology 2 (1), 47-76, 2019
1782019
Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 …
GM Villeirs, GO De Meerleer, PJ De Visschere, VH Fonteyne, ...
European journal of radiology 77 (2), 340-345, 2011
1442011
Salvage lymph node dissection for nodal recurrent prostate cancer: a systematic review
G Ploussard, G Gandaglia, H Borgmann, P De Visschere, I Heidegger, ...
European urology 76 (4), 493-504, 2019
1332019
Multidisciplinary approach to prostatitis
V Magri, M Boltri, T Cai, R Colombo, S Cuzzocrea, P De Visschere, ...
Archivio Italiano di Urologia e Andrologia 90 (4), 227-248, 2018
1332018
Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma
N Sundahl, G Vandekerkhove, K Decaestecker, A Meireson, ...
European urology 75 (5), 707-711, 2019
1122019
Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant …
P De Visschere, N Lumen, P Ost, K Decaestecker, E Pattyn, G Villeirs
Clinical radiology 72 (1), 23-32, 2017
1002017
Role of MRI in follow-up after focal therapy for prostate carcinoma
PJ De Visschere, GO De Meerleer, JJ Futterer, GM Villeirs
American Journal of Roentgenology 194 (6), 1427-1433, 2010
972010
What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging?
PJL De Visschere, L Naesens, L Libbrecht, C Van Praet, N Lumen, ...
European radiology 26, 1098-1107, 2016
942016
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU …
A Horwich, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ...
Annals of Oncology 30 (11), 1697-1727, 2019
902019
External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node dissection
G Gandaglia, A Martini, G Ploussard, N Fossati, A Stabile, P De Visschere, ...
European urology 78 (2), 138-142, 2020
892020
Clinical and imaging tools in the early diagnosis of prostate cancer, a review
P De Visschere, W Oosterlinck, G De Meerleer, G Villeirs
Journal of the Belgian Society of Radiology 93 (2), 62-70, 2010
742010
Detection of clinically significant prostate cancer: short dual–pulse sequence versus standard multiparametric MR imaging—a multireader study
BK Barth, PJL De Visschere, A Cornelius, C Nicolau, HA Vargas, D Eberli, ...
Radiology 284 (3), 725-736, 2017
732017
Role of multiparametric magnetic resonance imaging in early detection of prostate cancer
PJL De Visschere, A Briganti, JJ Fütterer, P Ghadjar, H Isbarn, C Massard, ...
Insights into imaging 7, 205-214, 2016
702016
Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate
PJL De Visschere, A Vral, G Perletti, E Pattyn, M Praet, V Magri, ...
European radiology 27, 2095-2109, 2017
622017
Nodal oligorecurrent prostate cancer: anatomic pattern of possible treatment failure in relation to elective surgical and radiotherapy treatment templates
A De Bruycker, E De Bleser, K Decaestecker, V Fonteyne, N Lumen, ...
European Urology 75 (5), 826-833, 2019
612019
Post-treatment complications of soft tissue tumours
LG Shapeero, PJL De Visschere, KL Verstraete, B Poffyn, R Forsyth, ...
European journal of radiology 69 (2), 209-221, 2009
552009
Population screening for prostate cancer: an overview of available studies and meta‐analysis
N Lumen, V Fonteyne, G De Meerleert, P Ost, G Villeirs, A Mottrie, ...
International journal of urology 19 (2), 100-108, 2012
522012
Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies?
G Ploussard, H Borgmann, A Briganti, P De Visschere, JJ Fütterer, ...
World journal of urology 37, 243-251, 2019
512019
系统目前无法执行此操作,请稍后再试。
文章 1–20